Enlivex Therapeutics Reports Q1 Net Loss $7.2M Vs $8.2M YoY
Portfolio Pulse from Benzinga Newsdesk
Enlivex Therapeutics reported a Q1 net loss of $7.2 million, a decrease from the previous month's $8.2 million loss.
June 26, 2023 | 12:26 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Enlivex Therapeutics' Q1 net loss decreased to $7.2 million from $8.2 million month-over-month.
Enlivex Therapeutics' Q1 net loss has decreased by $1 million compared to the previous month, which could be seen as a positive sign for the company's financial performance. This may lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100